ClinicalTrials.Veeva

Menu

Strategic Daytime Napping Enhances Agility and Lowers Perceived Exertion

P

Princess Nourah Bint Abdulrahman University

Status

Completed

Conditions

Healthy Participants

Treatments

Behavioral: No Nap Condition (N0)
Behavioral: Strategic Napping Protocol

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

This study investigates how short daytime naps affect physical performance and perceived exertion in competitive male soccer players. Using a repeated-measures crossover design, sixteen athletes from the U17 and U19 teams of Yeni Malatyaspor completed three experimental sessions separated by 48 hours. Each session involved one of three conditions: no nap (N0), a 25-minute nap (N25), or a 45-minute nap (N45). Participants' agility, repeated-sprint ability, and exertion levels were tested after each condition. Objective sleep data were collected with Fitbit Charge 6 devices, and subjective measures included the Hooper Index, Profile of Mood States, and sleep quality scales.

The study aimed to determine whether strategic napping could acutely improve agility and reduce fatigue during anaerobic performance tasks in soccer players. It was hypothesized that longer naps would enhance agility and lower perceived exertion but would not significantly affect repeated-sprint performance.

Full description

repeated-measures crossover design was conducted to examine the acute effects of strategic daytime naps on anaerobic performance in competitive male soccer players. Sixteen players from the Yeni Malatyaspor U17 and U19 teams participated voluntarily. Each participant completed three test sessions under randomized conditions: no nap (N0), 25-minute nap (N25), and 45-minute nap (N45), with a 48-hour recovery period between sessions.

Before testing, all participants underwent familiarization sessions to adapt to nap protocols and performance tests. The nap sessions were held in dark, quiet rooms maintained at ~22°C. Fitbit Charge 6 devices objectively verified nap compliance and duration. Participants abstained from caffeine, alcohol, and strenuous activity for at least 24 hours before testing.

To minimize sleep inertia, physical performance testing began 60 minutes after awakening. The test battery included the Pro Agility Test (to assess change-of-direction speed) and the Repeated-Sprint Ability (RSA) Test (6 × 30 m sprints with 20-second recovery). Heart rate during warm-up and ratings of perceived exertion (RPE) were recorded for standardization and subjective effort assessment.

Subjective measures included the Morningness-Eveningness Questionnaire (MEQ), Hooper Index, Pittsburgh Sleep Quality Index (PSQI), Profile of Mood States (POMS), and Visual Analogue Scales (VAS) for sleep quality and alertness. All players were identified as intermediate chronotypes according to the MEQ.

Anthropometric measurements (height, weight, BMI) were obtained using standardized equipment. Statistical analyses were conducted with SPSS v29, using repeated-measures ANOVA with Bonferroni correction to compare conditions. Effect sizes (ηp², Cohen's dz) and correlations between psychological and performance variables were calculated.

The study hypothesized that short daytime naps would enhance agility and reduce perceived exertion, with longer naps (45 min) providing greater benefits. However, due to the multifactorial nature of repeated-sprint performance, no significant improvements were expected in RSA results. The findings contribute to understanding individualized recovery strategies for soccer players and optimizing nap duration for performance enhancement.

Enrollment

16 patients

Sex

All

Ages

16 to 19 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Male soccer players aged 16-19 years.
  • Active members of the Yeni Malatyaspor U17 or U19 competitive teams.
  • In good general health, with no acute or chronic illness or injury.
  • Regularly engaged in organized soccer training and competition.
  • No habitual daytime napping routine.

Able and willing to comply with all study procedures and testing sessions.

  • Obtained informed consent (and parental consent for participants under 18 years).

Exclusion criteria

  • Current or recent (within 3 months) illness, injury, or infection.
  • Diagnosed sleep disorders or reported sleep problems on test days.
  • Hyperactivity or other conditions that could interfere with sleep or performance testing.
  • Use of medications, caffeine, or substances that could affect sleep or performance.
  • Failure to comply with pre-test instructions (e.g., abstaining from strenuous training, alcohol, or caffeine).
  • Inability to adhere to nap or testing protocols.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Single Blind

16 participants in 3 patient groups

No Nap Condition (N0)
Experimental group
Description:
Participants remained awake during the designated nap period in a quiet, dimly lit environment. No sleep was permitted. Following a 60-minute rest period, agility, repeated-sprint ability, and perceived exertion tests were conducted.
Treatment:
Behavioral: No Nap Condition (N0)
25-Minute Nap Condition (N25)
Experimental group
Description:
Participants took a 25-minute daytime nap opportunity at 14:00 in a dark, quiet room (\~22°C). Sleep was verified using Fitbit actigraphy. Sixty minutes after awakening, participants completed agility and repeated-sprint tests with exertion and recovery assessments.
Treatment:
Behavioral: Strategic Napping Protocol
45-Minute Nap Condition (N45)
Experimental group
Description:
Participants took a 45-minute daytime nap opportunity at 14:00 in a dark, quiet room (\~22°C). Sleep was verified via Fitbit actigraphy. After a 60-minute post-nap recovery period, agility, repeated-sprint, and perceived exertion measures were collected.
Treatment:
Behavioral: Strategic Napping Protocol

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems